Growth Metrics

electroCore (ECOR) Current Deferred Revenue (2022 - 2026)

electroCore's quarterly Current Deferred Revenue came in at $62000.0 in Q1 2026, little changed year-on-year from $62000.0 in Q1 2025, and up 24.0% quarter-over-quarter from $50000.0 in Q4 2025.

electroCore has reported Current Deferred Revenue for 5 years, with the latest figure at $62000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Deferred Revenue changed 0.0% year-over-year to $62000.0; the trailing twelve-month figure through Mar 2026 stood at $62000.0 (changed 0.0% YoY), and the FY2025 full-year result was $50000.0, down 35.9% from the prior year.
  • Current Deferred Revenue for Q1 2026 stood at $62000.0, up from $50000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $245000.0 in Q4 2023, with the low at $17000.0 in Q1 2023.
  • Average Current Deferred Revenue over 5 years is $92769.2, with a median of $68000.0 recorded in 2025.
  • Peak annual rise in Current Deferred Revenue reached 664.71% in 2024, while the deepest fall reached 76.67% in 2024.
  • Tracing ECOR's Current Deferred Revenue over 5 years: stood at $152000.0 in 2022, then jumped by 61.18% to $245000.0 in 2023, then tumbled by 68.16% to $78000.0 in 2024, then tumbled by 35.9% to $50000.0 in 2025, then rose by 24.0% to $62000.0 in 2026.
  • The last three Current Deferred Revenue figures came in at $62000.0 (Q1 2026), $50000.0 (Q4 2025), and $68000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 electroCore 92,394.96 -8.79 Mn 8.36 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 62,000.00
Dec 31, 2025 50,000.00
Jun 30, 2025 68,000.00
Mar 31, 2025 62,000.00
Dec 31, 2024 78,000.00
Sep 30, 2024 42,000.00
Jun 30, 2024 84,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 245,000.00
Sep 30, 2023 180,000.00
Jun 30, 2023 36,000.00
Mar 31, 2023 17,000.00
Dec 31, 2022 152,000.00